Search results
Results from the Tech24 Deals Content Network
In April 2019, following a large-scale ring-vaccination scheme in the DRC outbreak, the WHO published the preliminary results of its research, in association with the DRC's Institut National pour la Recherche Biomedicale, into the effectiveness of the ring vaccination program, stating that the rVSV-ZEBOV-GP vaccine had been 97.5% effective at stopping Ebola transmission, relative to no ...
rVSV-ZEBOV. VSV-EBOV or rVSV-ZEBOV, sold under the brand name Ervebo, is a vaccine based on the vesicular stomatitis virus which was genetically modified to express a surface glycoprotein of Zaire Ebola virus. [ 16][ 17] In November 2019, the European Commission granted a conditional marketing authorization. [ 18]
1976 Zaire Ebola virus outbreak. 2014 DR Congo outbreak. Kivu Ebola epidemic. List of epidemics and pandemics. v. t. e. Researchers believe that a 2-year-old boy who lived in the village of Meliandou, Guéckédou Prefecture, Guinea was the index case of the current Ebola virus disease epidemic. The boy died in December 2013.
A stockpile of half-a-million Ebola vaccine doses was established by Gavi and other global health partners in 2019 for use in outbreaks of haemorrhagic fever, which has an average fatality rate of ...
Vaccine. There is a vaccine to prevent Ebola—the FDA approved the Ebola vaccine rVSV-ZEBOV, aka Ervebo, in late 2019. However, the vaccine only targets Zaire ebolavirus, which has caused the ...
Western African Ebola epidemic. Note: current estimates suggest that between 17 per cent and 70 per cent of Ebola cases were unreported, [ 11] suggesting a total number of cases between 34,513 and 94,486. The 2013–2016 epidemic of Ebola virus disease, centered in West Africa, was the most widespread outbreak of the disease in history.
The vaccine, developed by the pharmaceutical giant Merck, is known as Ervebo. It's the first human Ebola vaccine to be approved by the EU. Ervebo was first engineered by the Public Health Agency ...
A month ago the European Union issued marketing authorization for a vaccine to prevent the Ebola virus in adults, and now the FDA has approved it. While noting that Ebola cases in the US have been ...